SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-15-000926
Filing Date
2015-03-03
Accepted
2015-03-03 16:32:24
Documents
18
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT tbuff_10k.htm 10-K 1877481
2 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT tbuff_ex105.htm EX-10.4 172929
3 CONSULTING AGREEMENT tbuff_ex106.htm EX-10.5 32016
4 CONSENT tbuff_ex23.htm EX-23 3237
5 CERTIFICATION tbuff_311.htm EX-31.1 15969
6 CERTIFICATION tbuff_312.htm EX-31.2 15926
7 CERTIFICATION tbuff_321.htm EX-32.1 7289
8 CERTIFICATION tbuff_322.htm EX-32.2 7298
15 img001.jpg GRAPHIC 8962
16 img002.jpg GRAPHIC 11506
17 img003.jpg GRAPHIC 10810
18 img004.jpg GRAPHIC 163053
  Complete submission text file 0001354488-15-000926.txt   7485197

Data Files

Seq Description Document Type Size
9 tbuff-20141231.xml EX-101.INS 801651
10 tbuff-20141231.xsd EX-101.SCH 64233
11 tbuff-20141231_cal.xml EX-101.CAL 60892
12 tbuff-20141231_def.xml EX-101.DEF 108121
13 tbuff-20141231_lab.xml EX-101.LAB 354885
14 tbuff-20141231_pre.xml EX-101.PRE 259689
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31198 | Film No.: 15669567
SIC: 2834 Pharmaceutical Preparations